Medication info
Arotatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Arotatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
Youn Life Sciences Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201803135 · Approved 2018.07.30

Summary

Main use
Improvement of hyperlipidemia (such as familial hypercholesterolemia in children) and reduction of cardiovascular disease risk
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended starting dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The starting and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be measured within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this drug higher than 20 mg in pediatric patients.). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Youn Life Sciences Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (such as familial hypercholesterolemia in children) and reduction of cardiovascular disease risk

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular intervention
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps reduce the risk of cardiovascular disease. It is particularly effective in decreasing the risk of myocardial infarction and stroke, the need for vascular intervention, and chronic stable angina in adults aged 55 and over or those with multiple risk factors, including smoking, hypertension, and low HDL cholesterol. Additionally, it reduces the risk of myocardial infarction and stroke in type 2 diabetes patients who have risk factors such as retinopathy, albuminuria, smoking, or hypertension. For patients with clinical evidence of heart disease, it can lower the risks of myocardial infarction, stroke, vascular interventions, hospitalization for congestive heart failure, and angina. It also improves cholesterol and triglyceride levels in patients with hyperlipidemia, serving as an adjunct in some patients with dyslipidemia who do not respond to dietary modifications. In pediatric patients with heterozygous familial hypercholesterolemia, it helps improve total cholesterol and LDL cholesterol levels. In summary, this drug is widely used for reducing the risk of cardiovascular disease and treating dyslipidemia.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended starting dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The starting and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be measured within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this drug higher than 20 mg in pediatric patients.). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause abnormal muscle symptoms, so if severe muscle pain, weakness, or cramps occur, discontinue use immediately and consult your physician. This drug may affect liver function; therefore, it should not be used in individuals with liver disease or abnormal liver function test results. Pregnant women, women who may become pregnant, and breastfeeding women should not take this medication and must use appropriate contraception beforehand. This medication is not indicated for children under 10 years old or patients with muscle diseases. Patients with a history of alcohol abuse or liver disease should use this drug cautiously and undergo regular liver function tests. The risk of side effects may increase if this medication is taken alongside certain antibiotics, antifungals, and antivirals; inform your doctor or pharmacist if you are taking other medications. Report any symptoms such as muscle pain, fatigue, or fever to your healthcare provider, and blood tests should be conducted to check for muscle damage. This medication contains lactose, and therefore, patients with lactose intolerance should avoid it. Be cautious when consuming grapefruit juice while taking this medication, as it may increase serum drug concentrations and the risk of side effects. Elderly patients or those with reduced kidney function are at a higher risk of muscle-related side effects and require careful monitoring during treatment. There is no specific antidote for overdose; treatment should be symptomatic, and liver function and muscle damage should be assessed. Keep out of reach of children and do not transfer the medication to other containers.

Side effects

Weakness, lethargy, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal distension, dyspepsia, nausea, diarrhea, abdominal pain, vomiting, belching, pancreatitis, throat pain, laryngeal pain, nosebleed, insomnia, nightmares, headache, dizziness, sensory disturbances, decreased sensation, altered taste, amnesia, peripheral neuropathy, myalgia, arthralgia, limb pain, musculoskeletal pain, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, rupture-related complications, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, vasculitis, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, vascular neurogenic edema, erythema multiforme, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), toxic epidermal necrolysis, gynecomastia, abnormal liver function tests, elevated serum CK, positive urine leukocytes, leukopenia, anemia, low testosterone, elevated cholinesterase, elevated TSH, elevated ACTH, low aldosterone, elevated potassium, increased BUN, cerebral infarction, palpitations, tachycardia, vomiting, abdominal abnormalities, cholestasis, cholestatic jaundice, abnormal liver function tests, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, glossitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, peptic ulcer, dysphagia, melena, gingival bleeding, acute exacerbation, bronchitis, rhinitis, pneumonia, dyspnea, asthma, sensory disturbances, vertigo, photosensitivity reactions, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional instability, ataxia, torticollis, facial paralysis, hyperkinesia, depression, tension increase, myositis, muscle disorders, arthritis, bursitis, synovitis, myasthenia gravis, tendon contracture, elevated serum myoglobin, contact dermatitis, skin dryness, sweating, acne, eczema, skin ulcers, erectile dysfunction, urinary tract infections, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgent urination, abnormal ejaculation, uterine bleeding, color change in urine, lethargy, vasomotor edema, chest pain, angina, facial swelling, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive errors, ocular hemorrhage, hearing loss, glaucoma, visual disturbances, taste loss, dysgeusia, sleep disturbances, amnesia, depression, interstitial lung disease, sexual dysfunction, diabetes, cognitive impairment, severe muscle weakness, ocular muscle weakness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.